Ticker Short Interest

KLRS Short Interest Intelligence

Kalaris Therapeutics, Inc. positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Bearish Exhaustion Watch

KLRS is classified as Neutral. Latest reported short interest is 502.6K shares; short interest changed -34.1%, price moved -0.2% since the previous report, short interest is in the 14th percentile, and days to cover is in the 14th percentile. Trend context is weak.

Setup Score32/100Neutral
Reported Short Interest502.6K-34.1% vs prior report
Days To Cover5.3714.29 percentile
Price Reaction-0.2%since previous short report
Squeeze Pressure7crowding, trend, and pressure
Bearish Conviction20shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

7

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

20

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

14

Latest short interest is 502.6K shares and days to cover is 5.37.

Divergence

27

Short interest fell while price fell. Shorts are covering despite weak price action, which can suggest the easy bearish pressure may be fading.

Report History

KLRS Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 502578 762669 -34.1% 5.37 93575
15 Jun 2026 762669 801523 -4.9% 10.90 69947
29 May 2026 801523 804374 -0.4% 10.29 77879
15 May 2026 804374 805754 -0.2% 7.89 101925
30 Apr 2026 805754 842687 -4.4% 8.86 90988
15 Apr 2026 842687 995274 -15.3% 9.48 88874
31 Mar 2026 995274 919448 8.3% 14.58 68245

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.